This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
Companies in this article
Tris Pharma, a specialty pharmaceutical company that develops innovative drug delivery technologies, announced the US Food and Drug Administration (FDA) has approved first-ever generic of TUSSIONEX, an Extended-Release Suspension containing hydrocodone polistirex and chlorpheniramine polistirex.
This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.